[Antistressor effect of delta-sleep-inducing peptide in hypokinetic stress].
Mendzheritskiĭ. A M AM; Makletsova. M G MG; Uskova. N I NI; Choraian. I O IO; Mikhaleva. I I II
Key Findings
- Hypokinetic stress disrupts levels of several neurotransmitter amino acids in the brain.
- DSIP injection restores these neurotransmitter levels toward normal.
- DSIP reduces stress‑induced alterations in enzymes that process GABA.
- DSIP normalizes lipid peroxidation (POL) in the brain, indicating reduced oxidative stress.
Practical Outcomes
- For biohackers, DSIP appears to have a protective effect against stress‑related brain chemistry disturbances. While the data are preliminary and likely from animal models, the findings suggest DSIP could be explored as a supplement to mitigate stress‑induced neurochemical imbalances and oxidative damage. Users should await more human research before integrating DSIP into regular protocols.
Summary
The study found that giving delta-sleep‑inducing peptide (DSIP) to subjects under low‑activity stress helped keep brain chemicals like GABA, glutamate, aspartate and homocarnosine at normal levels, reduced stress‑related enzyme changes, and protected brain lipids from damage.
Abstract
The influence of DSIP injection on the levels of neurotransmitters during hypokinetic stress was studied. It was shown that hypokinesia produced considerable changes in the levels of GABA glutamate, aspartate and homocarnosine. The injection of DSIP normalized the level of neurotransmitter amino acids. Administration of DSIP also reduced stress-induced changes in the activity of enzymes of GABA metabolism. Stress protective effect of DSIP was also demonstrated by normalising of the POL of lipids in brain.
Study Information
pubmed
1991